Evidence map›Paper›PMID 39402908›Full record

ReviewExperimental physiology2024

Left ventricular unloading to facilitate ventricular remodelling in heart failure: A narrative review of mechanical circulatory support.

Fatima Kayali, Owais Tahhan, Guglielmo Vecchio, Matti Jubouri, Judi M Noubani, Damian M Bailey, Ian M Williams, Wael I Awad, Mohamad Bashir

Abstract readReview
In one paragraph

Review in Experimental physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fatima KayaliUniversity Hospitals Sussex NHS Foundation Trust, Brighton and Hove, Sussex, UK.
Owais TahhanAston Medical School, Aston University, Birmingham, UK.
Guglielmo VecchioUniversity Hospitals Sussex NHS Foundation Trust, Brighton and Hove, Sussex, UK.
Matti JubouriHull York Medical School, University of York, York, UK.ORCID https://orcid.org/0000-0001-6725-6164
Judi M NoubaniFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0009-0004-6847-4357
Damian M BaileyNeurovascular Research Laboratory, Faculty of Life Sciences and Education, University of South Wales, Pontypridd, UK.ORCID https://orcid.org/0000-0003-0498-7095
Ian M WilliamsDepartment of Vascular Surgery, University Hospital of Wales, Cardiff, UK.
Wael I AwadDepartment of Cardiothoracic Surgery, Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Mohamad BashirNeurovascular Research Laboratory, Faculty of Life Sciences and Education, University of South Wales, Pontypridd, UK.ORCID https://orcid.org/0000-0002-1089-3629

Funding

Royal Society Wolfson Research Fellowship WM170007
6 · The paper itself

Abstract

Heart failure represents a dynamic clinical challenge with the continuous rise of a multi-morbid and ageing population. Yet, the evolving nature of mechanical circulatory support offers a variety of means to manage candidates who might benefit from such interventions. This narrative review focuses on the role of the main mechanical circulatory support devices, such as ventricular assist device, extracorporeal membrane oxygenation, Impella and TandemHeart, in the physiological process of ventricular unloading and remodelling in heart failure, highlighting their characteristics, mechanism and clinical outcomes. The outcome measures described include physiological changes (i.e., stroke volume or preload and afterload), intracardiac pressure (i.e., end-diastolic pressure) and extracardiac pressure (i.e., pulmonary capillary wedge pressure). Overall, all the above mechanical circulatory support strategies can facilitate the unloading of the ventricular failure through different mechanisms, which subsequently affects the ventricular remodelling process. These physiological changes start immediately after ventricular assist device implantation. The devices are indicated in different but overlapping populations and operate in distinctive ways; yet, they have evidenced performance to a favourable standard to improve cardiac function in heart failure, although this proved variable for different devices, and further high-quality trials are vital to assess their clinical outcomes further. Both Impella and TandemHeart are indicated mainly in cardiogenic shock and high-risk percutaneous coronary intervention patients; at the time the literature was evaluated, both devices were found to yield a significant improvement in haemodynamics but not in survival. Nevertheless, the choice of device strategy should be based on individual patient factors, including indication, to optimize clinical outcomes.

Indexed as

Heart-Assist DevicesHeart FailureVentricular RemodelingExtracorporeal Membrane OxygenationHeart VentriclesHumansVentricular Function, Leftheart failureleft ventricular unloadingmechanical circulatory supportventricular remodelling

Identifiers

PMID39402908
PMCPMC11522852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.